CIA
OFIX icon

Cape Investment Advisory’s Orthofix Medical OFIX Stock Holding History

Cape Investment Advisory’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150
Closed -$2.02K – 1096
2023
Q4 		$2.02K Buy
+150
New +$1.76K ﹤0.01% 921

Other funds holding OFIX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Cape Investment Advisory's OFIX Position: Q1 2024 in Review

Cape Investment Advisory sold out of Orthofix Medical (OFIX) in Q1 2024, closing a stake of 150 shares — an estimated $2.02K sold.

Cape Investment Advisory first reported a position in OFIX in Q4 2023 and held it in 1 quarter. The position peaked at $2.02K in Q4 2023. 136 funds tracked by Wall St. Rank hold OFIX as of Q1 2024.

  • Cape Investment Advisory reported no remaining Orthofix Medical position as of Q1 2024 after selling out during the quarter.
  • Cape Investment Advisory sold 150 Orthofix Medical shares in Q1 2024, an estimated $2.02K.
  • Cape Investment Advisory first reported a position in Orthofix Medical in Q4 2023 and held it in 1 quarter.
  • Cape Investment Advisory's Orthofix Medical position peaked at $2.02K in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2024.

Based on Cape Investment Advisory's 13F filing for Q1 2024, filed 21 Jun 2024.